In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation.
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics
Crimi, C;Iemmolo, M;Crimi, N
2016-01-01
Abstract
In asthma, exacerbations and poor disease control are linked to airway allergic inflammation. Serum periostin has been proposed as a systemic biomarker of eosinophilic inflammation. This pilot study aims at evaluating whether in patients with moderate asthma, higher baseline levels of serum periostin are associated with a greater risk of exacerbation.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Higher serum levels of periostin and the risk of exacerbations in moderate asthmatics.pdf
accesso aperto
Tipologia:
Versione Editoriale (PDF)
Dimensione
456.62 kB
Formato
Adobe PDF
|
456.62 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
